no chance of this being an issue.
These are the most common types of cancer, and the administration of a single dose of the CART is standard. The process for creating the CART is also defined GMP manufacturing guidelines.
in summary, easy to recruit patients, standard process for manufacturing and administration.
- Forums
- ASX - By Stock
- Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial
CHM
chimeric therapeutics limited
Add to My Watchlist
33.3%
!
0.4¢

no chance of this being an issue. These are the most common...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $12.99M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $949 | 312.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
70 | 67782438 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 91927011 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
70 | 67782438 | 0.003 |
26 | 26746044 | 0.002 |
13 | 54414000 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 91927011 | 27 |
0.005 | 33248062 | 21 |
0.006 | 17929018 | 21 |
0.007 | 6512518 | 7 |
0.008 | 7317101 | 5 |
Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |